-
18213-100An affinity probe which allows carbaprostacyclin to be detected in complexes with transmembrane receptors and/or nucleic or protein binding partners.
-
18213-500An affinity probe which allows carbaprostacyclin to be detected in complexes with transmembrane receptors and/or nucleic or protein binding partners.
-
18240-1A derivative of &beta-glycyrrhetinic acid a major metabolite of glycyrrhizin, one of the main constituents of licorice, with anti-ulcerative and anti-inflammatory properties inhibits 11&beta-HSD1 conversion of cortisol to cortisone, which
-
18240-10A derivative of &beta-glycyrrhetinic acid a major metabolite of glycyrrhizin, one of the main constituents of licorice, with anti-ulcerative and anti-inflammatory properties inhibits 11&beta-HSD1 conversion of cortisol to cortisone, which
-
18240-25A derivative of &beta-glycyrrhetinic acid a major metabolite of glycyrrhizin, one of the main constituents of licorice, with anti-ulcerative and anti-inflammatory properties inhibits 11&beta-HSD1 conversion of cortisol to cortisone, which
-
18240-5A derivative of &beta-glycyrrhetinic acid a major metabolite of glycyrrhizin, one of the main constituents of licorice, with anti-ulcerative and anti-inflammatory properties inhibits 11&beta-HSD1 conversion of cortisol to cortisone, which
-
18606-1An agonist of the sigma-1 receptor (Ki = 10.4 nM) also binds the serotonin 5-HT3 and muscarinic acetylcholine receptors (Kis = 7.9 and 76 nM, respectively).
-
18606-100An agonist of the sigma-1 receptor (Ki = 10.4 nM) also binds the serotonin 5-HT3 and muscarinic acetylcholine receptors (Kis = 7.9 and 76 nM, respectively).
-
18606-500An agonist of the sigma-1 receptor (Ki = 10.4 nM) also binds the serotonin 5-HT3 and muscarinic acetylcholine receptors (Kis = 7.9 and 76 nM, respectively).
-
19010-1A stable analog of TXA2 unlike other TP receptor agonists, it inhibits platelet aggregation (IC<sub>50</sub> = 4-5 µM).
-
19010-100A stable analog of TXA2 unlike other TP receptor agonists, it inhibits platelet aggregation (IC<sub>50</sub> = 4-5 µM).
-
19010-500A stable analog of TXA2 unlike other TP receptor agonists, it inhibits platelet aggregation (IC<sub>50</sub> = 4-5 µM).